** Shares of Rua Bioscience RUA.NZ rise 7.7% to NZ$0.028, eyeing their strongest trading session since May 21, if gains sustain
** Medical cannabis firm reaches settlement with Australian peer Cann Group CAN.AX following legal proceedings initiated by Rua in February 2024
** Proceedings on damage claims for breach of contractual rights to exclusively sell Cann's products in Australia
** Cann shares rise as much as 7.1% to A$0.02 in early hours of trade
** Rua adds both cos have executed new supply agreements to support their respective operations in New Zealand and Australia
** More than 129,000 shares change hands, 1.9 times its 30-day avg volume
** Rua down 3.5% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。